HBOT is FDA-approved for diabetic foot ulcer support. The Zhang 2022 meta-analysis of 20 RCTs (1,263 patients) found significantly higher complete-healing rates, shorter healing times, and lower major-amputation rates with HBOT vs. standard care.
Diabetic Wound Healing.
Zhang et al. 2022 (Asian Journal of Surgery) pooled 20 RCTs with 1,263 participants. HBOT increased complete-healing rate (RR 1.901; 95% CI 1.484–2.435; p<0.0001), shortened healing time by an average of 19.36 days (95% CI -28.75 to -9.97; p<0.001), and reduced major amputation incidence (RR 0.518; 95% CI 0.323–0.830; p<0.01). The Kranke 2015 Cochrane review of HBOT for chronic wounds reached compatible conclusions.
Why HBOT works for the injured brain.
The diabetic wounds prescription.
The standard Saturate protocol for diabetic wounds follows the cited trial below — the most widely-referenced study for this condition. The card to the right shows the base parameters drawn directly from it.
Your personalized version will adjust based on chronicity, prior HBOT experience, age, and any contraindications flagged in screening. Most adjustments are minor — pressure caps, ramp-up modifications, slight course length changes — but they materially affect safety and outcome.
Diabetic Wounds
- Required pressure
- 2.4 ATA
- Required oxygen concentration
- 100%
- Session length
- 90 minutes
- Frequency
- 5 sessions per week
- Total course
- 30 sessions
What the literature documents at each stage.
Below is what published trials report at each phase of the diabetic wounds protocol. Individual results vary — these are the documented patterns from the named cohorts, not predictions of your outcome.
Adjustment & acclimation.
Body adjusts to pressurized oxygen. Most participants report no acute changes — early sessions establish safety patterns and chamber familiarity.
Per published protocolSubjective changes begin.
Reported improvements in sleep quality, energy, and mental clarity start to emerge. Quantitative testing has not yet shown statistically significant change at this stage in published trials.
Mid-protocol observationsMeasurable changes documented.
Standardized assessments show statistically significant improvement in published trials at this stage. Imaging (SPECT, DTI, fMRI) documents biological correlates of the clinical changes.
Per cited trialsEffects persist.
Gains documented at end of protocol have held at 6-month follow-up in published cohorts. Some sub-domains continued improvement after the protocol ended.
Per published follow-ups